DOUGLAS RICHARD
SEC insider (Form 3/4/5 filer). CIK 0001021015. Director at NOVAVAX INC (NVAX) and 2 other issuers. 16 reported Form 4/5 transactions since Sep 2024; latest on Jun 20, 2026. Located in LEXINGTON, MA.
Companies DOUGLAS RICHARD has filed insider reports for
- NOVAVAX INC (NVAX): Director
- MAXCYTE, INC. (MXCT): Director
- Aldeyra Therapeutics, Inc. (ALDX): Director
DOUGLAS RICHARD
CIK: 0001021015
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (16 total)
- Jun 20, 2026NVAX
NOVAVAX INC
ExerciseDirect18.9K shares- - Jun 18, 2026NVAX
NOVAVAX INC
AwardDirectRestricted Stock Units
14.2K shares- - Jun 18, 2026NVAX
NOVAVAX INC
AwardDirectStock Option (Right to Buy)
21.3K shares- - Jun 17, 2026MXCT
MAXCYTE, INC.
AwardDirect30.4K shares- - Jun 9, 2026ALDX
Aldeyra Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
19.9K shares- - Jun 9, 2026ALDX
Aldeyra Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
70K shares- - Jun 9, 2026ALDX
Aldeyra Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
2.3K shares- - Mar 19, 2026ALDX
Aldeyra Therapeutics, Inc.
PurchaseDirect70K shares at avg. $1.40$98K - Aug 13, 2025MXCT
MAXCYTE, INC.
PurchaseDirect80K shares at avg. $1.39$111K - Jun 20, 2025NVAX
NOVAVAX INC
AwardDirectRestricted Stock Units
18.9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 20, 2026 |  NVAX NOVAVAX INC | Exercise | 18,880 | - | $0 | Direct |
| Jun 18, 2026 | NVAX NOVAVAX INC | Award Restricted Stock Units | 14,180 | - | - | Direct |
| Jun 18, 2026 | NVAX NOVAVAX INC | Award Stock Option (Right to Buy) | 21,270 | - | - | Direct |
| Jun 17, 2026 |  MXCT MAXCYTE, INC. | Award | 30,421 | - | $0 | Direct |
| Jun 9, 2026 |  ALDX Aldeyra Therapeutics, Inc. | Award Stock Option (Right to Buy) | 19,909 | - | - | Direct |
| Jun 9, 2026 | ALDX Aldeyra Therapeutics, Inc. | Award Stock Option (Right to Buy) | 70,000 | - | - | Direct |
| Jun 9, 2026 | ALDX Aldeyra Therapeutics, Inc. | Award Stock Option (Right to Buy) | 2,323 | - | - | Direct |
| Mar 19, 2026 | ALDX Aldeyra Therapeutics, Inc. | Purchase | 70,000 | $1.40 | $98,000 | Direct |
| Aug 13, 2025 | MXCT MAXCYTE, INC. | Purchase | 80,000 | $1.39 | $111,040 | Direct |
| Jun 20, 2025 | NVAX NOVAVAX INC | Award Restricted Stock Units | 18,884 | - | - | Direct |
1-10 of 16 transactions